The use of the bioflavonoid compounds in the prevention or reduction in severity of erythroblastosis fetalis.
D001205:Ascorbic Acid / Q000627:therapeutic use*; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005333:Fetus; D005419:Flavonoids / Q000627:therapeutic use*; D006402:Hematologic Diseases; D006801:Humans; D014815:Vitamins
D005419:Flavonoids; D014815:Vitamins; D001205:Ascorbic Acid
ERYTHROBLASTOSIS, FETAL/prevention and control; VITAMIN C/therapeutic use; VITAMIN P/therapeutic use